Abstract:In advancing discrete-based computational cancer models towards clinical applications, one faces the dilemma of how to deal with an ever growing amount of biomedical data that ought to be incorporated eventually in one form or another. Model scalability becomes of paramount interest. In an effort to start addressing this critical issue, here, we present a novel multi-scale and multi-resolution agent-based in silico glioma model. While ‘multi-scale’ refers to employing an epidermal growth factor receptor (EGFR)-driven molecular network to process cellular phenotypic decisions within the micro-macroscopic environment, ‘multi-resolution’ is achieved through algorithms that classify cells to either active or inactive spatial clusters, which determine the resolution they are simulated at. The aim is to assign computational resources where and when they matter most for maintaining or improving the predictive power of the algorithm, onto specific tumor areas and at particular times. Using a previously described 2D brain tumor model, we have developed four different computational methods for achieving the multi-resolution scheme, three of which are designed to dynamically train on the high-resolution simulation that serves as control. To quantify the algorithms’ performance, we rank them by weighing the distinct computational time savings of the simulation runs vs. the methods’ ability to accurately reproduce the high-resolution results of the control. Finally, to demonstrate the flexibility of the underlying concept, we show the added value of combining the two highest-ranked methods. The main finding of this work is that by pursuing a multi-resolution approach, one can reduce the computation time of a discrete-based model substantially while still maintaining a comparably high predictive power. This hints at even more computational savings in the more realistic 3D setting over time, and thus appears to outline a possible path to achieve scalability for the all-important clinical translation.

Multiscale Agent-Based Cancer Modeling

Simulation and computational analysis of multiscale graph agent-based tumor model

Simulating Brain Tumor Heterogeneity with a Multiscale Agent-Based Model:Linking Cell Signaling, Motility Bias & Expansion Rate

Simulating brain tumor heterogeneity with a multiscale agent-based model: Linking molecular signatures, phenotypes and expansion rate

Multi-scale, Multi-Resolution Brain Cancer Modeling.

Agent-based approaches for biological modeling in oncology: A literature review

Development of a Three-Dimensional Multiscale Agent-Based Tumor Model: Simulating Gene-Protein Interaction Profiles, Cell Phenotypes & Multicellular Patterns in Brain Cancer

Development of a Three-Dimensional Multiscale Agent-Based Tumor Model: Simulating Gene-Protein Interaction Profiles, Cell Phenotypes and Multicellular Patterns in Brain Cancer

Exploring the Role of Genetic and Environmental Features in Colorectal Cancer Development: An Agent-Based Approach

Theoretical Biology and Medical Modelling Open Access Simulating Non-small Cell Lung Cancer with a Multiscale Agent-based Model

Multi-scale Agent-Based Modeling on Melanoma and Its Related Angiogenesis Analysis.

Agent-based modeling in cancer biomedicine: applications and tools for calibration and validation

Agent‐Based Modeling in Molecular Systems Biology

Agent-based modeling of tumor-immune interactions reveals determinants of final tumor states

A seven-step guide to spatial, agent-based modelling of tumour evolution

Developing an Agent-Based Drug Model to Investigate the Synergistic Effects of Drug Combinations

Strategies for Efficient Numerical Implementation of Hybrid Multi-scale Agent-Based Models to Describe Biological Systems

Integrating mechanism-based T cell phenotypes into a model of tumor-immune cell interactions

Developing a multiscale, multi-resolution agent-based brain tumor model by graphics processing units

Bridging Scales: a Hybrid Model to Simulate Vascular Tumor Growth and Treatment Response

Bridging the gap between the micro- and the macro-world of tumors